Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (HKG:2315)
Hong Kong · Delayed Price · Currency is HKD 47.00
+0.40 (0.86%)
Jul 9, 2026, 4:08 PM HKT
HKG:2315 Market Cap
HKG:2315 has a market cap or net worth of 46.49 billion as of July 9, 2026. Its market cap has increased by 443.88% in one year.
Market Cap
46.49B
Enterprise Value
46.22B
Revenue
1.78B
Ranking
n/a
PE Ratio
57.72
Stock Price
47.00
Market Cap Chart
Since September 1, 2022, HKG:2315's market cap has increased from 10.31B to 46.49B, an increase of 350.72%. That is a compound annual growth rate of 47.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 9, 2026 | 46.49B | 97.10% |
| Dec 31, 2025 | 23.58B | 594.71% |
| Dec 31, 2024 | 3.39B | -29.05% |
| Dec 29, 2023 | 4.78B | -53.29% |
| Dec 30, 2022 | 10.24B | -0.67% |
| Sep 1, 2022 | 10.31B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sichuan Kelun-Biotech Biopharmaceutical | 111.79B |
| Akeso | 87.19B |
| Sino Biopharmaceutical | 85.94B |
| RemeGen | 68.87B |
| 3SBio | 44.26B |
| Shanghai Junshi Biosciences | 36.60B |
| Shanghai Henlius Biotech | 34.57B |
| Genscript Biotech | 29.04B |